v3.26.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 6 Months Ended
Jun. 30, 2026
Accounting Policies [Abstract]  
SCHEDULES OF CONCENTRATION OF RISK, BY RISK FACTOR

Following is a summary of customers who accounted for more than ten percent (10%) of the Company’s revenues for the three and six months ended June 30, 2026, and 2025, and their accounts receivable balance as of June 30, 2026:

 

  

Sales %

Three Months
Ended
June 30,

2026

  

Sales %

Six Months
Ended
June 30,

2026

  

Sales %

Three Months
Ended
June 30,

2025

  

Sales %

Six Months
Ended
June 30,

2025

  

Accounts
receivable balance
June 30,

2026

 
Customer A   100.0%   97.8%   67.6%   58.2%  $8,766 
Customer B   N/A    N/A    N/A    11.3%  $- 
Customer C   N/A    N/A    14.2%   11.4%  $- 
Customer D   N/A    N/A    16.3%   N/A   $- 
SCHEDULE OF DISAGGREGATION OF REVENUE

The following table disaggregates our revenue by major source for the three and six months ended June 30, 2026, and 2025:

 

   2026   2025   2026   2025 
   Three months ended
June 30,		   Six months ended
June 30,		 
   2026   2025   2026   2025 
Sourced and distributed products  $-   $19,454   $315   $22,478 
OED Installations   41,645    44,277    97,383    83,510 
Total  $41,645   $63,731   $97,698   $105,988 
SCHEDULE OF DERIVATIVE INSTRUMENTS

The following table represents the Company’s derivative instruments that are measured at fair value on a recurring basis as of June 30, 2026, and December 31, 2025, for each fair value hierarchy level:

 

June 30, 2026  Derivative
Liabilities		   Total 
Level I  $-   $- 
Level II  $-   $- 
Level III  $9,840,324   $9,840,324 

 

December 31, 2025  Derivative
Liabilities		   Total 
Level I  $-   $- 
Level II  $-   $- 
Level III  $4,193,434   $4,193,434 
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

 

  

June 30,

2026

  

June 30,

2025

 
Convertible preferred stock (1)   7,774,290    2,724,684 
Unexercised common stock purchase warrants (1)   1,271,405    546,405 
Convertible notes payable (1)   75,556,308    330,713 
Promissory notes payable (1)   7,257,995    746,463 
Total   91,859,998    4,348,265 

 

(1) The potentially dilutive shares included in the above table are limited whereby the conversion or exercise cannot result in the beneficial owner holding more than 4.99% of the then outstanding shares of common stock subsequent to any conversion or exercise. These shares were excluded from the diluted per share calculation because the effect of including these potential shares was anti-dilutive.